Type II collagen supplementation reduces osteoarthritis pain and improves joint function
Static snapshot — vote, comment, and submit papers on the live app.
Open in Live App →- Inconclusive
Management and Amelioration of Knee Joint Osteoarthritis in Adults Using a Novel High-Functional Bovine Collagen Peptide as a Nutritional Therapy: A Double-Blind, Prospective, Multicentric, Randomized, Active and Placebo Controlled, Five-Arm, Clinical Study to Evaluate the Efficacy, Safety, and Tolerability.
Published 2024Reviewer Insight5/27/2026This study tested whether bovine collagen protein supplements could reduce knee pain and improve function in people with osteoarthritis, and found that all active supplement groups showed significantly less pain and better joint scores than the placebo group after 90 days. However, several serious problems prevent firm conclusions:
- Product mismatch: The supplements tested are hydrolyzed bovine collagen peptides (Type I/III source), not Type II collagen as stated in the claim
- Tiny group sizes: Each of the 5 arms had only ~20 participants — too small to draw reliable conclusions
- No correction for multiple tests: 60 separate statistical comparisons were run with no adjustment, inflating the chance of false-positive results
- Key confounder missing: Exercise habits — which directly affect knee pain — were never measured or accounted for
- Manufacturer conflict: The company that profits from positive results funded the trial and employed most of the researchers
Snapshot built: 2026-06-19